Several fibroblast defining markers including alpha smooth muscle actin (ASMA), CD90/Thy-1, fibroblast activation protein (FAP), platelet derived growth factor receptor-alpha and -beta (PDGFRa, -b) have been studied individually as prognostic markers as well as active functional regulators of tumor progression. The gene discussed is FAP; the disease is neoplasm.